Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study

The Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) is a prospective longitudinal study designed to enroll 1000 hospitalized patients with COVID-19 (NCT04378777). IMPACC collects detailed clinical, laboratory, and radiographic data along with longitudinal biologic sampling of blood and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouphael, Nadine, Maecker, Holden, Montgomery, Ruth R., Diray-Arce, Joann, Kleinstein, Steven H., Altman, Matthew C., Bosinger, Steven E., Eckalbar, Walter, Guan, Leying, Hough, Catherine L., Krammer, Florian, Langelier, Charles, Levy, Ofer, McEnaney, Kerry, Peters, Bjoern, Rahman, Adeeb, Rajan, Jayant V., Sigelman, Steven, Steen, Hanno, van Bakel, Harm, Ward, Alyssa, Wilson, Michael R., Woodruff, Prescott, Zamecnik, Colin R., Augustine, Alison D., Ozonoff, Al, Reed, Elaine F., Becker, Patrice M., Higuita, Nelson Agudelo, Atkinson, Mark A., Baden, Lindsey R., Bime, Christian, Brakenridge, Scott C., Calfee, Carolyn S., Cairns, Charles B., Corry, David, Davis, Mark M., Ehrlich, Lauren I. R., Haddad, Elias K., Erle, David J., Fernandez-Sesma, Ana, Hafler, David A., Kheradmand, Farrah, Kraft, Monica, McComsey, Grace A., Melamed, Esther, Messer, William, Metcalf, Jordan, Nadeau, Kari C., Pulendran, Bali, Sarwal, Minnie, Schaenman, Joanna, Sekaly, Rafick, Shaw, Albert C., Simon, Viviana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Resources
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713959/
https://www.ncbi.nlm.nih.gov/pubmed/34376480
http://dx.doi.org/10.1126/sciimmunol.abf3733
Descripción
Sumario:The Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) is a prospective longitudinal study designed to enroll 1000 hospitalized patients with COVID-19 (NCT04378777). IMPACC collects detailed clinical, laboratory, and radiographic data along with longitudinal biologic sampling of blood and respiratory secretions for in-depth testing. Clinical and laboratory data are integrated to identify immunologic, virologic, proteomic, metabolomic, and genomic features of COVID-19–related susceptibility, severity, and disease progression. The goals of IMPACC are to better understand the contributions of pathogen dynamics and host immune responses to the severity and course of COVID-19 and to generate hypotheses for identification of biomarkers and effective therapeutics, including optimal timing of such interventions. In this report, we summarize the IMPACC study design and protocols including clinical criteria and recruitment, multisite standardized sample collection and processing, virologic and immunologic assays, harmonization of assay protocols, high-level analyses, and the data sharing plans.

Ejemplares similares